HomeIPA • NASDAQ
add
Immunoprecise Antibodies Ltd
Previous close
$0.35
Day range
$0.33 - $0.40
Year range
$0.32 - $2.60
Market cap
10.79M USD
Avg Volume
838.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | 5.26M | -7.47% |
Operating expense | 6.89M | -1.12% |
Net income | -4.00M | -12.17% |
Net profit margin | -75.98 | -21.22% |
Earnings per share | — | — |
EBITDA | -3.65M | -28.46% |
Effective tax rate | 16.25% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.91M | -41.85% |
Total assets | 59.30M | -22.57% |
Total liabilities | 26.44M | 16.30% |
Total equity | 32.85M | — |
Shares outstanding | 27.92M | — |
Price to book | 0.29 | — |
Return on assets | -19.02% | — |
Return on capital | -23.50% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -4.00M | -12.17% |
Cash from operations | -1.82M | -159.83% |
Cash from investing | -263.00K | -33.50% |
Cash from financing | 2.70M | 765.68% |
Net change in cash | 455.00K | 129.30% |
Free cash flow | -356.12K | -5.75% |
About
Founded
1983
Headquarters
Website
Employees
87
